Stem cell nations working together for a stem cell world: Foreword

Regenerative Medicine

Volumn 5, Issue 1, 2010, Pages 1-4

  Mason, Chris ^a   Manzotti, Elisa ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b FUTURE SCIENCE GROUP   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; EDITORIAL; EMBRYONIC STEM CELL; HEALTH CARE COST; HEALTH INSURANCE; INTERNET; MEDICAL LITERATURE; MEDICAL RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; REGENERATIVE MEDICINE; RESEARCH ETHICS; RISK MANAGEMENT; STEM CELL; STEM CELL TRANSPLANTATION; TOURISM; TRAVEL;

COOPERATIVE BEHAVIOR; EMBRYO RESEARCH; FETAL RESEARCH; HUMANS; INTERNATIONAL COOPERATION; STEM CELLS;

EID: 77649283575     PISSN: 17460751     EISSN: None     Source Type: Journal    
DOI: 10.2217/rme.09.85     Document Type: Editorial

References (22)

1. Ryan AR, Sanders AN, Wang DD, Levine AD: Tracking the rise of stem cell tourism. Regen. Med. 5(1), 27-33 (2010).
2. McMahon DS, Thorsteinsdóttir H, Singer PA, Daar AS: Cultivating regenerative medicine innovation in China. Regen. Med. 5(1), 35-44 (2010).
3. Knoppers BM, Isasi R, Willemse L: Stem Cell Charter. Regen. Med. 5(1), 5-6 (2010).
4. Qiu J: Trading on hope. Nat. Biotechnol. 27(9), 790-792 (2009).
5. Wong KM: Culturing stem cell awareness. Cell Stem Cell 5, 470-471 (2009).
6. Savulescu J, Saunders R: The "Hinxton Group" considers transnational stem cell research. Hastings Cent. Rep. 36(3), 1 p following 48 (2006).
7. Siegel B: Organization profile: genetics policy institute. Regen. Med. 4(3), 365-370 (2009).
8. Regenberg AC, Hutchinson LA, Schanker B, Mathews DJ: Medicine on the fringe: stem cell-based interventions in advance of evidence. Stem Cells 27(9), 2312-2319 (2009).
9. Horowitz MD, Rosensweig JA, Jones CA: Medical tourism: globalization of the healthcare marketplace. MedGenMed 9(4), 33 (2007).
10. Arunanondchai J, Fink C: Trade in health services in the ASEAN region. Health Promot Int. 21(Suppl. 1), 59-66 (2006).
11. Hyun I, Lindvall O, Ahrlund-Richter L et al.: New ISSCR guidelines underscore major principles for responsible translational stem cell research. Cell Stem Cell 3(6), 607-609 (2008).
12. Lau D, Ogbogu U, Taylor B, Stafinski T, Menon D, Caulfield T: Stem cell clinics online: the direct-to-consumer portrayal of stem cell medicine. Cell Stem Cell 3(6), 591-594 (2008).
13. Lindvall O, Hyun I: Medical innovation versus stem cell tourism. Science 324(5935), 1664-1665 (2009).
14. Schult J: Beauty from Afar: A Medical Tourist's Guide to Affordable and Quality Cosmetic Care Outside the U.S. Stewart, Tabori & Chang, NY, USA (2006).
15. Mason C, Manzotti E: Regen: the industry responsible for cell-based therapies. Regen. Med. 4(6), 783-785 (2009).
16. Kiatpongsan S, Sipp D: Medicine. Monitoring and regulating offshore stem cell clinics. Science 323(5921), 1564-1565 (2009).
17. Herrera S: Leaders and laggards in the stem cell enterprise. Nat. Biotechnol. 23(7), 775-777 (2005).
18. Willemse L, Lyall D, Rudnicki M: Catalyzing stem cell research. Regen. Med. 3(5), 761-764 (2008).
19. Brevignon-Dodin L, Livesey F: What can be learnt from the Japanese regulatory approach to tissue engineered products? Regen. Med. 2(6), 967-971 (2007).
20. Salter B, Cooper M, Dickins A, Cardo V: Stem cell science in India: emerging economies and the politics of globalization. Regen. Med. 2(1), 75-89 (2007). (Pubitemid 46824415)
21. Salter B, Cooper M, Dickins A: China and the global stem cell bioeconomy: an emerging political strategy? Regen. Med. 1(5), 671-683 (2006).
22. Sipp D: The rocky road to regulation. Nat. Rep. Stem Cells (2009) (Epub ahead of print).